Cargando…
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
Purpose: Combining siRNA and other chemotherapeutic agents into one nanocarrier can overcome the multidrug resistance (MDR) phenomenon by synergistically MDR relative genes silencing and elevated chemotherapeutic activity. Most of these systems are typically fabricated through complicated procedures...
Autores principales: | Chen, Mengchun, Wang, Ledan, Wang, Fang, Li, Fan, Xia, Weiliang, Gu, Hongchen, Chen, Yijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526930/ https://www.ncbi.nlm.nih.gov/pubmed/31190812 http://dx.doi.org/10.2147/IJN.S198511 |
Ejemplares similares
-
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023) -
AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity
por: Gu, Dowoon, et al.
Publicado: (2021) -
Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
por: Egorova, Anna A., et al.
Publicado: (2019) -
Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy
por: Zhang, Chun-ge, et al.
Publicado: (2016) -
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
por: Zhao, Yi, et al.
Publicado: (2016)